Use of botulinum toxin therapy for treatment of urological neurological conditions
View Patent ↗The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.
1. A method for treating a disorder selected from the group consisting of benign prostatic hyperplasia, abacterial prostatis, or prostatodynia in a patient suffering from benign prostatic hyperplasia, abacterial prostatis, or prostatodynia, the method comprising administering a botulinum toxin to the prostate of the patient, thereby treating the disorder.
2. The method of claim 1 , wherein the patient is a human.
3. The method of claim 1 , wherein the patient is a human male.
4. The method of claim 1 , wherein the botulinum toxin is a botulinum toxin type A.
5. The method of claim 1 , wherein the botulinum toxin is administered in a pharmaceutically acceptable formulation selected from the group consisting of:
a liquid, a cream, an emulsion, a suspension, and a solution.
6. The method of claim 1 , wherein the botulinum toxin is administered in an amount of up to 2500 units.
7. The method of claim 1 , wherein the botulinum toxin is administered in an injectable, pharmaceutically acceptable formulation selected from the group consisting of a liquid, a cream, an emulsion, a suspension, and a solution.
8. A method for treating a disorder selected from the group consisting of benign prostatic hyperplasia, abacterial prostatis, or prostatodynia in a patient suffering from benign prostatic hyperplasia, abacterial prostatis or prostatodynia, the method comprising administering urethroscopically a botulinum toxin type A into the prostate of the patient; in an amount of up to 2500 units, thereby treating the disorder.